MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with C

Clonazepam

Clonazepam 1mg tablets

Use with caution

Stability notes for Clonazepam 1mg tablets

Light sensitive medicine. Store in light resistant container. Anecdotal reports of use in MCAs for up to 2 weeks (low quality evidence).

Provenance

This recommendation is based on the products Clonazepam 1mg tablets (Neuraxpharm UK Ltd).

Suppliers

Clonazepam 1mg tablets (A A H Pharmaceuticals Ltd)
Clonazepam 1mg tablets (Alliance Healthcare (Distribution) Ltd)
Clonazepam 1mg tablets (Neuraxpharm UK Ltd)

Clonazepam 2mg tablets

Use with caution

Stability notes for Clonazepam 2mg tablets

Light sensitive medicine. Store in light resistant container. Anecdotal reports of use in MCAs for up to 2 weeks (low quality evidence).

Provenance

This recommendation is based on the products Clonazepam 2mg tablets (Neuraxpharm UK Ltd).

Suppliers (16) of Clonazepam 2mg tablets
Clonazepam 2mg tablets (A A H Pharmaceuticals Ltd)
Clonazepam 2mg tablets (Accord-UK Ltd)
Clonazepam 2mg tablets (Alissa Healthcare Research Ltd)
Clonazepam 2mg tablets (Alliance Healthcare (Distribution) Ltd)
Clonazepam 2mg tablets (Almus Pharmaceuticals Ltd)
Clonazepam 2mg tablets (Aristo Pharma Ltd)
Clonazepam 2mg tablets (Celix Pharma Ltd)
Clonazepam 2mg tablets (Drugsrus Ltd)
Clonazepam 2mg tablets (Manx Healthcare Ltd)
Clonazepam 2mg tablets (Medihealth (Northern) Ltd)
Clonazepam 2mg tablets (Necessity Supplies Ltd)
Clonazepam 2mg tablets (Neuraxpharm UK Ltd)
Clonazepam 2mg tablets (Novumgen Ltd)
Clonazepam 2mg tablets (Phoenix Healthcare Distribution Ltd)
Clonazepam 2mg tablets (Sigma Pharmaceuticals Plc)
Clonazepam 2mg tablets (Teva UK Ltd)

Clonazepam 500microgram oral lyophilisates sugar free

No stability information

Stability notes for Clonazepam 500microgram oral lyophilisates sugar free

There are no stability notes for this medicine.

Supplier

Klonopin 0.5mg oral lyophilisates (Imported (United States))

Clonazepam 500microgram orodispersible tablets

No stability information

Stability notes for Clonazepam 500microgram orodispersible tablets

There are no stability notes for this medicine.

Supplier

Clonazepam 500microgram orodispersible tablets (Special Order)

Clonazepam 500microgram tablets

Use with caution

Stability notes for Clonazepam 500microgram tablets

Light sensitive medicine. Store in light resistant container. Anecdotal reports of use in MCAs for up to 2 weeks (low quality evidence).

Provenance

This recommendation is based on the products Clonazepam 500mcg tablets (Neuraxpharm UK Ltd).

Suppliers (16) of Clonazepam 500microgram tablets
Clonazepam 500microgram tablets (A A H Pharmaceuticals Ltd)
Clonazepam 500microgram tablets (Accord-UK Ltd)
Clonazepam 500microgram tablets (Alissa Healthcare Research Ltd)
Clonazepam 500microgram tablets (Alliance Healthcare (Distribution) Ltd)
Clonazepam 500microgram tablets (Almus Pharmaceuticals Ltd)
Clonazepam 500microgram tablets (Aristo Pharma Ltd)
Clonazepam 500microgram tablets (Celix Pharma Ltd)
Clonazepam 500microgram tablets (Drugsrus Ltd)
Clonazepam 500microgram tablets (Manx Healthcare Ltd)
Clonazepam 500microgram tablets (Medihealth (Northern) Ltd)
Clonazepam 500microgram tablets (Necessity Supplies Ltd)
Clonazepam 500microgram tablets (Neuraxpharm UK Ltd)
Clonazepam 500microgram tablets (Novumgen Ltd)
Clonazepam 500microgram tablets (Phoenix Healthcare Distribution Ltd)
Clonazepam 500microgram tablets (Sigma Pharmaceuticals Plc)
Clonazepam 500microgram tablets (Teva UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.